Navigation Links
IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
Date:10/28/2008

MOUNTAIN VIEW, Calif., Oct. 28 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its third quarter 2008 financial results after the market closes on Tuesday, November 4, 2008. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Tuesday, November 4, 2008 to discuss the results of the quarter and other business developments.

Interested parties may access the live conference call via telephone by dialing (866) 250-4375 (US) or (303) 262-2161 (International), or by visiting the Company's website at http://www.iridex.com. A telephone replay will be available beginning on Tuesday, November 4, 2008 through Tuesday, November 11, 2008 by dialing (800) 405-2236 (US) or (303) 590-3000 (International) and entering Passcode 11122023#.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. IRIDEX Reports First Quarter 2008 Financial Results
2. IRIDEX Announces First Quarter 2008 Conference Call and Release Date
3. IRIDEX Reports Fourth Quarter and Full Year 2007 Financial Results
4. IRIDEX Announces Fourth Quarter and Full Year 2007 Conference Call and Release Date
5. IRIDEX Reports Third Quarter Financial Results
6. IRIDEX Announces Third Quarter 2007 Conference Call and Release Date
7. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
8. James B. Hawkins Appointed to IRIDEX Board of Directors
9. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor
10. William Moore Appointed to IRIDEX Board of Directors
11. IRIDEX Announces Closing of $5.0 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... If you are thinking of a visit to San Francisco ... October is the perfect time to visit. , Business Architecture Associates is pleased to offer ... for individuals, as a 4-½ day package for individuals, and as 4-½ day corporate package ...
(Date:5/24/2017)... ... May 24, 2017 , ... Technique, technique, technique – with a ... lifting weights for strength training and exercise or simply lifting heavy objects, advises Dr. ... position is everything,” Dr. Chang says. “Improper technique in lifting anything heavy or an ...
(Date:5/23/2017)... ... 23, 2017 , ... PM360, the premier information resource for ... winners of its 3rd Annual ELITE Awards. The ELITE (Exceptional • Leaders • ... industry today. , Out of more than 500 submissions, 100 winners were selected ...
(Date:5/23/2017)... ... May 23, 2017 , ... London, May 23, 2017: ... serve earlier this month as a Guest Speaker and Contributor to a weeklong series ... and Common Purpose. , Walter Schindler and SAIL Capital ...
(Date:5/23/2017)... IN (PRWEB) , ... May 23, 2017 , ... ... the availability of video chat as a standard feature on its secure clinical ... from text to voice to video depending on the type and urgency of ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017 CSSi, the global leader in ... research industry, is proud to announce the launch of ... website features both enriched content and a customized layout ... the company,s already well-established position as the top global ... "After many months of hard work, we are delighted ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/8/2017)... FLINT, Mich. , May 8, 2017  Diplomat ... WRB Communications, Inc. ("WRB"), a health care ... . WRB specializes in relationship management ... organizations. WRB will ... of Diplomat,s commercialization support services for manufacturers, biotech firms, ...
Breaking Medicine Technology: